Photo from wikipedia
Data are lacking about the benefit of adjuvant endocrine therapy (ET) in older patients with multiple comorbidities. The authors sought to determine the effect of ET on the survival of… Click to show full abstract
Data are lacking about the benefit of adjuvant endocrine therapy (ET) in older patients with multiple comorbidities. The authors sought to determine the effect of ET on the survival of older patients who had multiple comorbidities and estrogen receptor (ER)‐positive/human epidermal growth factor receptor 2 (HER2)‐negative, pathologic node‐negative (pN0) breast cancer.
Keywords:
endocrine therapy;
adjuvant endocrine;
therapy older;
receptor;
cancer;
older patients
Journal Title: Cancer
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Cancer
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!